1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Ms E Walmsley
| |||
b)
|
Position/status
|
Chief Executive Officer
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on shares held through the Company's Share Reward Plan.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2597
|
21
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Ms D Conrad
| |||
b)
|
Position/status
|
Chief People Officer
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on shares held through the Company's Share Reward Plan.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2597
|
4
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Mr J Ford
| |||
b)
|
Position/status
|
SVP and Group General Counsel, Legal and Compliance
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on shares held through the Company's Share Reward Plan.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2597
|
5
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Ms S Jackson
| |||
b)
|
Position/status
|
SVP, Global Communications and CEO Office
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on shares held through the Company's Share Reward Plan.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2597
|
52
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Mr D Jackson
| |||
b)
|
Position/status
|
PCA of Ms S Jackson (SVP, Global Communications and CEO Office)
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on shares held through the Company's Share Reward Plan.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2597
|
22
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Mr L Miels
| |||
b)
|
Position/status
|
Chief Commercial Officer
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on shares held through the Company's Share Reward Plan.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2597
|
2
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Mr D Redfern
| |||
b)
|
Position/status
|
President Corporate Development
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on shares held through the Company's Share Reward Plan.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2597
|
62
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Mr R Simard
| |||
b)
|
Position/status
|
President, Global Supply Chain
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on shares held through the Company's Share Reward Plan.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2597
|
21
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Mr P Thomson
| |||
b)
|
Position/status
|
President, Global Affairs
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on shares held through the Company's Share Reward Plan.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2597
|
38
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Ms D Waterhouse
| |||
b)
|
Position/status
|
CEO, ViiV Healthcare
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on shares held through the Company's Share Reward Plan.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2597
|
50
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Ms V Whyte
| |||
b)
|
Position/status
|
Company Secretary
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023 on shares held through the Company's Share Reward Plan.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2597
|
47
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Ms S Jackson
| |||
b)
|
Position/status
|
SVP, Global Communications and CEO Office
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2318
|
8
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Mr D Jackson
| |||
b)
|
Position/status
|
PCA of Ms S Jackson (SVP, Global Communications and CEO Office)
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2318
|
8
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Ms V Whyte
| |||
b)
|
Position/status
|
Company Secretary
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023.
| |||
c)
|
Price(s) and volume(s)
|
Price(s) |
Volume(s)
| ||
£14.2318
|
25
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Mr I Whyte
| |||
b)
|
Position/status
|
PCA of Ms V Whyte (Company Secretary)
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2318
|
838
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
| ||||
a)
|
Name
|
Ms D Connor
| |||
b)
|
Position/status
|
PCA of Mr R Connor (President, Global Vaccines)
| |||
c)
|
Initial notification/amendment
|
Initial notification
| |||
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
|
Name
|
GSK plc
| |||
b)
|
LEI
|
5493000HZTVUYLO1D793
| |||
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
| ||||
a)
|
Description of the financial instrument
|
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
ISIN:GB00BN7SWP63
| |||
b)
|
Nature of the transaction
|
Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 12 January 2023.
| |||
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
| ||
£14.2318
|
338
| ||||
d)
|
Aggregated information
|
N/A (single transaction)
| |||
Aggregated volume
Price
| |||||
e)
|
Date of the transaction
|
2023-01-12
| |||
f)
|
Place of the transaction
|
London Stock Exchange (XLON)
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
GSK plc published this content on 13 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 January 2023 17:19:06 UTC.